US BioShield II promise to be more attractive and less risky for industry participants
This article was originally published in Clinica
Executive Summary
With bioterrorism preparedness one of the top Republican issues in Congress this year, members of the Senate health education labour and pensions (HELP) committee have begun work on legislation that would make it more attractive for companies to develop products designed to counter a biological attack.